Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Olumiant
Descriptions
Baricitinib is used alone or together with other medicines (eg, methotrexate, DMARDs) to treat moderately to severely active rheumatoid arthritis in patients who have taken other medicines (eg, tumor necrosis factor or TNF antagonist) that did not work well.
Baricitinib is also used to treat coronavirus disease 2019 (COVID-19) in hospitalized patients requiring oxygen or assistance with breathing.
Baricitinib is a Janus kinase (JAK) inhibitor that works on the immune system.
This medicine is available only with your doctor's prescription for rheumatoid arthritis. This medicine is to be given only by or under the immediate supervision of your doctor for COVID-19.
This product is available in the following dosage forms:
Portions of this document last updated: June 01, 2022
Copyright © 2022 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.